Mohammad Hirmand

Mohammad Hirmand is the founder of Avenzo Therapeutics, Inc., founded in 2022, where the title held is Chief Medical Officer & Executive Vice President.
Current jobs include Director at Atavistik Bio, Inc. and Independent Director at Whitehawk Therapeutics, Inc. Former jobs include Associate Director-Clinical Research at Amgen, Inc., Director-Oncology Development at SuperGen, Inc., Senior Director-Clinical Development at Nuvelo, Inc., Senior Director-Clinical Development at ARCA biopharma, Inc., Manager-Clinical Data at Tularik, Inc., Chief Medical Officer at Peloton Therapeutics, Inc. from 2017 to 2019, Chief Medical Officer & Executive Vice President at Turning Point Therapeutics, Inc. from 2019 to 2022, Manager-Market Development & Product Evaluation at Innoviva, Inc., Chief Medical Officer at Medivation LLC (California) from 2015 to 2017, and Principal at Theravance Biopharma Us LLC.
Education includes undergraduate degree from Cornell University and doctorate from Harvard Medical School.